Expert Video - How does my genetic mutation profile impact the treatment of my MDS?

Valeria Santini, MD, an expert in MDS from the University of Florence, discusses how your individual genetic mutation profile provides essential information on the prognosis for your MDS as well as specific treatments. She explains what a complex karyotype is, its role in myelodysplastic syndromes (MDS) progression, and how cytogenetic testing and the type and number of genetic mutations are important in treatment planning. The mutation profile can help doctors choose therapies targeted to the MDS progenitor cells.

  • Share with family and friends:

Click here to take our SURVEY
Your feedback is important to us! We will use your feedback to develop future areas of content about MDS which will help other patients, caregivers and families.


This educational activity has been developed by the Myelodysplastic Syndromes Foundation, Inc. and Mechanisms in Medicine Inc.

This activity is supported by an educational grant from Acceleron Pharma, Bristol-Myers Squibb, Celgene Corporation, Jazz Pharmaceuticals, Novartis Pharmaceuticals, and Takeda Oncology.

This website is part of the Animated Patient™ series developed by Mechanisms in Medicine Inc., to provide highly visual formats of learning for patients to improve their understanding, make informed decisions, and partner with their healthcare professionals for optimal outcomes.